USP22 and neoplasm: Because p53 mutation usually loss the transcriptional activity and responses to upstream signals differently [33, 34], p53-mediated repression of the USP22-FASN axis will be abolished in p53-mutated cancers, resulting in FASN stabilization, lipid accumulation, and tumor growth.